|
|
Article: CVS Caremark's Objectionable Drug Marketing Practices Raised at Massachusetts Joint Committee on Health Care Financing Hearing Today, According to CtW.
- Article from:
- Diabetes Week
- Article date:
- April 6, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Questions about CVS Caremark's objectionable drug marketing practices are being raised today by Massachusetts lawmakers who seek to outlaw the practice of selling, sharing or using patient and prescriber identifiable prescription information for marketing purposes. Some retail pharmacies and pharmacy benefit managers (PBMs), like CVS Caremark, use or sell prescription data in exchange for payments for marketing for drug companies and other purposes (see also Change to Win CtW).
"This legislation is necessary to stop companies like CVS Caremark from using prescription data for marketing purposes, which threatens our healthcare system and privacy," said Jasmin ...